Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-21-071200
Filing Date
2021-05-24
Accepted
2021-05-24 16:19:27
Documents
45
Period of Report
2021-02-28

Document Format Files

Seq Description Document Type Size
1 FORM 10-K tm2111726-1_10k.htm 10-K 649581
2 EXHIBIT 31.1 tm2111726d1_ex31-1.htm EX-31.1 9427
3 EXHIBIT 31.2 tm2111726d1_ex31-2.htm EX-31.2 9319
4 EXHIBIT 32.1 tm2111726d1_ex32-1.htm EX-32.1 5162
5 EXHIBIT 32.2 tm2111726d1_ex32-2.htm EX-32.2 5156
  Complete submission text file 0001104659-21-071200.txt   2524086

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bzyr-20210228.xml EX-101.INS 358505
7 XBRL TAXONOMY EXTENSION SCHEMA bzyr-20210228.xsd EX-101.SCH 33999
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bzyr-20210228_cal.xml EX-101.CAL 21891
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bzyr-20210228_def.xml EX-101.DEF 86435
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bzyr-20210228_lab.xml EX-101.LAB 256742
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bzyr-20210228_pre.xml EX-101.PRE 173808
Mailing Address 9432 KATY FREEWAY HOUSTON TX 77055
Business Address 12000 RICHMOND AVE HOUSTON TX 77082 (713) 335-5697
BURZYNSKI RESEARCH INSTITUTE INC (Filer) CIK: 0000724445 (see all company filings)

EIN.: 760136810 | State of Incorp.: DE | Fiscal Year End: 0228
Type: 10-K | Act: 34 | File No.: 000-23425 | Film No.: 21955192
SIC: 2835 In Vitro & In Vivo Diagnostic Substances